Literature DB >> 22440903

Vasculature and kidney complications in sickle cell disease.

Karl A Nath1, Zvonimir S Katusic.   

Abstract

Recent developments in sickle cell disease include the concept of a vasculopathic state and the classification of sickle cell disease into a hemolysis-endothelial dysfunction phenotype or a viscosity-vasoocclusion phenotype. The hemolysis-endothelial dysfunction phenotype largely reflects deficiency of or resistance to nitric oxide. In addition to discussing these areas, we suggest that the hemolysis-endothelial dysfunction phenotype also reflects the instability of sickle hemoglobin, the release of heme, and the induction of heme oxygenase-1. From these perspectives the renal complications of sickle cell disease are discussed and classified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440903      PMCID: PMC3338300          DOI: 10.1681/ASN.2011101019

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  38 in total

1.  Glomerular hyperfiltration in sickle cell disease.

Authors:  Raimund Hirschberg
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

2.  High prevalence of sickle cell trait in African Americans with ESRD.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Abhijit V Kshirsagar
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

3.  Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury.

Authors:  David P Basile; Jessica L Friedrich; Jasmina Spahic; Nicole Knipe; Henry Mang; Ellen C Leonard; Saeed Changizi-Ashtiyani; Robert L Bacallao; Bruce A Molitoris; Timothy A Sutton
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

4.  Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature.

Authors:  Jean-Philippe Haymann; Katia Stankovic; Pierre Levy; Virginie Avellino; Pierre-Louis Tharaux; Emmanuel Letavernier; Gilles Grateau; Laurent Baud; Robert Girot; François Lionnet
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

5.  Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia.

Authors:  Micheline Maier-Redelsperger; Pierre Lévy; François Lionnet; Katia Stankovic; Jean-Philippe Haymann; Guillaume Lefèvre; Virginie Avellino; Jean-Pierre Perol; Robert Girot; Jacques Elion
Journal:  Blood Cells Mol Dis       Date:  2010-09-15       Impact factor: 3.039

6.  Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula.

Authors:  Lu Kang; Satsuki Yamada; Melissa C Hernandez; Anthony J Croatt; Joseph P Grande; Julio P Juncos; Gregory M Vercellotti; Robert P Hebbel; Zvonimir S Katusic; Andre Terzic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-22

7.  Selective enhancement of contractions to α1-adrenergic receptor activation in the aorta of mice with sickle cell disease.

Authors:  Ramiro Juncos; Luis Juncos; Robert P Hebbel; Gregory M Vercellotti; Zvonimir S Katusic; Karl A Nath
Journal:  J Cardiovasc Pharmacol       Date:  2011-02       Impact factor: 3.105

8.  Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1.

Authors:  Kenneth I Ataga; Julia E Brittain; Dominic Moore; Susan K Jones; Ben Hulkower; Dell Strayhorn; Soheir Adam; Rupa Redding-Lallinger; Patrick Nachman; Eugene P Orringer
Journal:  Eur J Haematol       Date:  2010-06-03       Impact factor: 2.997

9.  Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia.

Authors:  Sevgi Gurkan; Kyla J Scarponi; Hilary Hotchkiss; Beth Savage; Richard Drachtman
Journal:  Pediatr Nephrol       Date:  2010-06-02       Impact factor: 3.714

Review 10.  Heme degradation and vascular injury.

Authors:  John D Belcher; Joan D Beckman; Gyorgy Balla; Jozsef Balla; Gregory Vercellotti
Journal:  Antioxid Redox Signal       Date:  2010-02       Impact factor: 8.401

View more
  35 in total

Review 1.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

2.  Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.

Authors:  Stéphane M Camus; João A De Moraes; Philippe Bonnin; Paul Abbyad; Sylvain Le Jeune; François Lionnet; Laurent Loufrani; Linda Grimaud; Jean-Christophe Lambry; Dominique Charue; Laurent Kiger; Jean-Marie Renard; Claire Larroque; Hervé Le Clésiau; Alain Tedgui; Patrick Bruneval; Christina Barja-Fidalgo; Antigoni Alexandrou; Pierre-Louis Tharaux; Chantal M Boulanger; Olivier P Blanc-Brude
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

3.  Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.

Authors:  Narendranath Reddy Chintagari; Julia Nguyen; John D Belcher; Gregory M Vercellotti; Abdu I Alayash
Journal:  Blood Cells Mol Dis       Date:  2014-12-22       Impact factor: 3.039

4.  Sickle cell trait and renal disease among African American U.S. Army soldiers.

Authors:  Jiaqi Hu; D Alan Nelson; Patricia A Deuster; Eric S Marks; Francis G O'Connor; Lianne M Kurina
Journal:  Br J Haematol       Date:  2019-03-11       Impact factor: 6.998

5.  Sickle Cell Trait and the Risk of ESRD in Blacks.

Authors:  Rakhi P Naik; Marguerite R Irvin; Suzanne Judd; Orlando M Gutiérrez; Neil A Zakai; Vimal K Derebail; Carmen Peralta; Michael R Lewis; Degui Zhi; Donna Arnett; William McClellan; James G Wilson; Alexander P Reiner; Jeffrey B Kopp; Cheryl A Winkler; Mary Cushman
Journal:  J Am Soc Nephrol       Date:  2017-03-09       Impact factor: 10.121

6.  Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.

Authors:  Kabir O Olaniran; Andrew S Allegretti; Sophia H Zhao; Maureen M Achebe; Nwamaka D Eneanya; Ravi I Thadhani; Sagar U Nigwekar; Sahir Kalim
Journal:  J Am Soc Nephrol       Date:  2019-12-06       Impact factor: 10.121

7.  Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.

Authors:  Amy Geard; Gift D Pule; Bernard Chetcha Chemegni; Valentina J Ngo Bitoungui; Andre P Kengne; Emile R Chimusa; Ambroise Wonkam
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

8.  Diffusion tensor imaging MRI of sickle cell kidney disease: initial results and comparison with iron deposition.

Authors:  Shannon B Donnola; Connie M Piccone; Lan Lu; Joshua Batesole; Jane Little; Katherine M Dell; Chris A Flask
Journal:  NMR Biomed       Date:  2018-01-19       Impact factor: 4.044

9.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

10.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.